11.2 Capital is a venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology that is headquartered in San Francisco, California and was founded in 2014 by Shelley Zhuang. The firm specializes in offering its early stage companies several services such as technical recruiting, partnerships, customer introductions, and follow-on financing.
Notable investments made by 11.2 Capital include: TigerGraph, WhiteOps, Avaamo, Ginkgo Bioworks, Forter, Aunransa, Bay Labs, Cruise, Vertical, Notable Labs, Savioke, Molecular Assemblies, Kindred, Deep Genomics, and Lucira Health.
Synthace is a software company based out of London, UK building automation software that gives biologists the ability to control and analyze the performance of lab hardware.
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
A company that allows developers build mobile AR applications, save and share AR content in physical spaces.
Lucira Health is a company developing and producing health diagnostic hardware that transforms a smartphone into a portable and real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids.
Passage AI is a Mountain View, Contra Costa County, California-based company.
Outlier is an Oakland, California-based company founded in 2015.